+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A double-blind, parallel-group, placebo-controlled, dose-ranging, multicenter study of intravenous granisetron in the treatment of postoperative nausea and vomiting in patients undergoing surgery with general anesthesia



A double-blind, parallel-group, placebo-controlled, dose-ranging, multicenter study of intravenous granisetron in the treatment of postoperative nausea and vomiting in patients undergoing surgery with general anesthesia



Journal of Clinical Anesthesia 9(8): 658-663



To compare the effectiveness of granisetron with placebo in the treatment of established postoperative nausea and vomiting (PONV). Randomized, placebo-controlled study. 34 hospitals in Europe, Scandinavia, and South Africa. 519 ASA physical status I, II, and III patients who developed PONV within 4 hours of the end of surgery performed with general anesthesia. Patients received a single intravenous dose of granisetron 0.1 mg, 1 mg, or 3 mg, or placebo when symptoms of nausea or vomiting were experienced. Additional rescue medication could be given at the investigator's discretion if nausea and vomiting were not controlled. At all doses investigated, granisetron was significantly more effective (p < or = 0.001) than placebo in controlling vomiting: 38%, 46%, and 49% of patients receiving granisetron, 0.1 mg, 1.0 mg, and 3.0 mg, respectively, experienced no vomiting in the first 24 hours following drug administration, compared with 20% receiving placebo. There was a statistically significant linear relationship between vomiting control and granisetron dose (p < 0.001). Survival distributions of time to resolution of vomiting confirmed the statistically significant difference between patients receiving granisetron and those receiving placebo. Granisetron was well tolerated: the most common adverse experiences were pain, constipation, anemia, and headache, and the incidence of adverse experiences was not statistically significantly higher in any of the granisetron groups than in the placebo group. Granisetron was significantly more effective than placebo in all groups. Further studies in specific subgroups may be warranted.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045058358

Download citation: RISBibTeXText

PMID: 9438895


Related references

A double blind, parallel group, placebo controlled dose ranging study of IV granisetron in the prevention of post-operative nausea and vomiting. Anesthesiology 81(3A): A1280, 1994

A randomized, double-blind, dose-ranging, pilot study of intravenous granisetron in the prevention of postoperative nausea and vomiting in patients undergoing abdominal hysterectomy1. European Journal of Anaesthesiology 22(10): 774-779, 2005

Efficacy of granisetron for the treatment of postoperative nausea and vomiting in women undergoing breast surgery: a randomised, double-blind, placebo-controlled trial. Clinical Drug Investigation 26(4): 203-208, 2006

A randomized double-blind study of prevention of postoperative nausea and vomiting with ondansetron, tropisetron, or granisetron in patients undergoing general anesthesia. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 29(1): 107-110, 2007

The Effect of Single-dose Intravenous Dexamethasone on Postoperative Pain and Postoperative Nausea and Vomiting in Patients Undergoing Surgery under Spinal Anesthesia: A Double-blind Randomized Clinical Study. Anesthesia Essays and Researches 12(2): 313-317, 2018

Effects of onclansetron and Granisetron on postoperative nausea and vomiting in adult patients undergoing laparoscopic cholecystectomy: A randomized, double-blind, placebo-controlled clinical trial. Current Therapeutic Research 68(5): 303-312, 2007

Treatment of postoperative emetic symptoms with granisetron in women undergoing abdominal hysterectomy: a randomized, double-blind, placebo-controlled, dose-ranging study. Current Therapeutic Research Clinical and Experimental 65(4): 321-329, 2004

Oral granisetron as prophylaxis for nausea and vomiting during fluorescein angiography. A multicentre, double-blind, randomised, parallel group, placebo-controlled study. Minerva Anestesiologica 64(12): 553-561, 1998

A randomized, double-blind, close-ranging, pilot study of intravenous granisetron in the prevention of postoperative nausea and vomiting in patients abdominal hysterectomy. European Journal of Anaesthesiology 22(10): 774-779, 2005

Multicenter, randomized, double-blind, ondansetron (ond)-controlled, dose-ranging, parallel group trial of the neurokinin-1 receptor antagonist (NK-1 RA) casopitant mesylate for chemotherapy-induced nausea/vomiting (CINV) in patients (pts) receiving moderately emetogenic chemotherapy (MEC). Journal of Clinical Oncology 24(18_Suppl): 8512-8512, 2016

Ondansetron in prophylaxis of postoperative nausea and vomiting in patients undergoing breast surgery: a placebo-controlled double blind study. Journal of the Indian Medical Association 102(2): 73, 2004

Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study. Journal of Clinical Oncology 16(2): 754-760, 1998

Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting: A multicenter, double-blind, placebo-controlled study. Acta Anaesthesiologica Scandinavica 41(7): 914-922, 1997

Single-dose intravenous casopitant in combination with ondansetron and dexamethasone for the prevention of oxaliplatin-induced nausea and vomiting: a multicenter, randomized, double-blind, active-controlled, two arm, parallel group study. Supportive Care in Cancer 20(7): 1471-1478, 2012

Alizapride and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic gynaecological surgery: A double-blind, randomised, placebo-controlled noninferiority study. European Journal of Anaesthesiology 33(2): 96, 2016